Acta Pharmacologica Sinica

Aims & Scope

APS (Acta Pharmacologica Sinica) encourages submissions from all areas of pharmacology and the life sciences.

Topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics and pharmacokinetics.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	8.4
2024	6.90

Journal Rank

Year	Value
2024	1112

Journal Citation Indicator

Year	Value
2024	6143

SJR (SCImago Journal Rank)

Year	Value
2024	2.297

Quartile

Year	Value
2024	Q1

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• PubMed
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

  Citation: 1912

  Authors: Yuan, Chan, Xin-feng, Wei, Shu-wen

• Amyloid beta: structure, biology and structure-based therapeutic development

  Citation: 1556

  Authors: Guo-fang, Ting-hai, Yan, Yu-ren, Yi, Karsten, H Eric

• Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases

  Citation: 1007

  Authors: Xiao-xia, Yan, Zheng-hong

• Engineering exosomes as refined biological nanoplatforms for drug delivery

  Citation: 981

  Authors: Xin, Kanokwan, Ila, Hongwei, Hebao, Duxin

• Mesenchymal stem cells: a new trend for cell therapy

  Citation: 755

  Authors: Xin, Xue, Zhi-peng, Fang-fang, Li, Yu-fang

• Androgen receptor: structure, role in prostate cancer and drug discovery

  Citation: 721

  Authors: MH Eileen, Jun, H Eric, Karsten, Eu-leong

• CB-Dock: a web server for cavity detection-guided protein–ligand blind docking

  Citation: 609

  Authors: Yang, Maximilian, Wen-tao, Mu-chun, Zhi-Xiong, Yang

• Tumor necrosis factor and cancer, buddies or foes?

  Citation: 591

  Authors: Xia, Yong

• miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges

  Citation: 541

  Authors: Shan-shan, Jing-peng, Ji-qun, Zhi-guo, Jonathan H, Yang, Lu

• New knowledge of the mechanisms of sorafenib resistance in liver cancer

  Citation: 535

  Authors: Yan-jing, Bo, Hong-yang, Lei

---